Erratum to: J Endocrinol Invest DOI 10.1007/s40618-016-0604-8
Unfortunately, the Figs. 1 and 3 were switched and wrongly published in the original version. The correct Figs. 1 and 3 and the respective caption are given in the following page.
The original version is also updated.
Change in a fasting glucose and b glycosylated haemoglobin (HbA1c) in the total safety analysis set over the study period
Change in a insulin-like growth factor-1 (IGF-1) and b IGF-1 standard deviation scores (IGF-1 SDS) in treatment naïve patients included in the efficacy analysis set over the study period
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s40618-016-0604-8.
Rights and permissions
About this article
Cite this article
Ferone, D., Profka, E., Gasco, V. et al. Erratum to: Long-term safety and efficacy of Omnitrope® in adults with growth hormone deficiency: Italian interim analysis of the PATRO Adults study. J Endocrinol Invest 40, 679–681 (2017). https://doi.org/10.1007/s40618-017-0664-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-017-0664-4